Surgical consideration in Hunter syndrome: a case of hydrocephalus and a case of epidural hematoma
- 34 Downloads
Hunter syndrome (HS) is a rare X-linked lysosomal storage disorder which affects multiple organ systems. Surgical intervention and general anesthesia should be used with caution because of significant airway complications.
Two HS patients underwent surgery with different prognosis are presented below. In the first case, symptoms of progressive disabilities on motor function, language, intelligence, and development last for 1 year in a 6-year-old boy; magnetic resonance imaging (MRI) showed severe hydrocephalus. Third ventriculostomy was performed in this patient to relieve the hydrocephalus. Unfortunately, this patient died postoperatively due to postsurgical tracheal collapse. In the second case, an 8-year-old girl was referred to our hospital with epidural hematoma because of a falling accident. Trephination surgery was performed under local anesthesia to remove the hematoma. Three days postsurgical, the patient was discharged uneventfully.
General anesthesia in HS patients was associated with poor prognosis due to respiratory complications. Local anesthesia and less intensified treatment should be recommended.
KeywordsHunter syndrome Surgery Complications Treatment
Compliance with ethical standards
Conflict of interest
The authors declare that the study was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- 1.Neufeld EU, Muenzer J (2001) The mucopolysaccharidoses. In: The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3421–3452Google Scholar
- 2.Gupta R, Pandey CB, Tripathi S (2014) Mucopolysaccharidosis type II (Hunter’s syndrome) - a clinical case report. Journal of Indian College of Cardiology 5:61–66Google Scholar
- 4.Scarpa M (2007) Mucopolysaccharidosis Type II. In: R.A. Pagon, T.D. Bird, C.R. Dolan, et al. (eds) GeneReviewsTM [Internet]. (Seattle (WA), USA)Google Scholar
- 5.Jones SA, Almassy Z, Beck M, Burt K, Clarke JT, Giugliani R, Hendriksz C, Kroepfl T, Lavery L, Lin SP, Malm G, Ramaswami R, Tincheva T, Wraith JE, investigators H (2009) Mortality and cause of death in mucopolysaccharidosis type II - a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis 32:534–543CrossRefGoogle Scholar
- 6.Schwartz GP, Cohen EJ (1998) Hydrocephalus in Maroteaux-Lamy syndrome. Arch Ophthalmol 116:400Google Scholar
- 8.Aliabadi H, Reynolds R, Powers CJ, Grant G, Fuchs H, Kurtzberg J (2010) Clinical outcome of cerebrospinal fluid shunting for communicating hydrocephalus in mucopolysaccharidoses I, II, and III: a retrospective analysis of 13 patients. Neurosurgery 67:1476–1481 discussion 1481–1472CrossRefGoogle Scholar
- 12.Nagano R, Takizawa S, Hayama N, Umemura S, Uesugi T, Nakagawa S, Okamoto S, Yanagimachi N, Takagi S (2007) Three-dimensional ct and histopathological findings of airway malacia in hunter syndrome. Tokai J Exp Clin Med 32:59–61Google Scholar
- 14.Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, Vellodi A, Martin R, Ramaswami U, Gucsavas-Calikoglu M, Vijayaraghavan S, Wendt S, Puga AC, Ulbrich B, Shinawi M, Cleary M, Piper D, Conway AM, Kimura A (2006) A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (hunter syndrome). Genet Med 8:465–473CrossRefGoogle Scholar
- 15.Muenzer J, Beck M, Eng C, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, Link B, Martin RA, Molter DW, Muñoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E (2009) Multidisciplinary management of Hunter syndrome. Pediatrics 124:1228–1239CrossRefGoogle Scholar
- 17.Parini R, Rigoldi M, Tedesco L, Boffi L, Brambilla A, Bertoletti S, Boncimino A, Del Longo A, De Lorenzo P, Gaini R, Gallone D, Gasperini S, Giussani C, Grimaldi M, Grioni D, Meregalli P, Messinesi G, Nichelli F, Romagnoli M, Russo P, Sganzerla E, Valsecchi G, Biondi A (2015) Enzymatic replacement therapy for hunter disease: up to 9 years experience with 17 patients. Mol Genet Metab Rep 3:65–74CrossRefGoogle Scholar
- 18.Mendelsohn NJ, Harmatz P, Bodaner O, Burton BK, Giugliani R, Jones SA, Lampe C, Malm G, Steiner RD, Parini R, Investigators HOS (2010) Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey. Genet Med 12:816–822CrossRefGoogle Scholar